Register for Updates | Search | Contacts | Site Map | Member Login

ICRP
««Prev  Next»» 

Radiation Dose to Patients from Radiopharmaceuticals - Addendum 3 to ICRP Publication 53

ICRP Publication 106

Ann. ICRP 38 (1-2), 2008


Abstract - In this report, the Commission provides biokinetic and dosimetric models for 33 radiopharmaceuticals, as well as recommendations related to breast feeding for mothers who have undergone a nuclear medicine investigation. The report is based on Addenda 39 to Publication 53. Addenda 37 have been available on the ICRP website (www.icrp.org) as interim reports. The work has been carried out by a Joint Task Group of ICRP Committees 2 and 3.

This publication provides biokinetic models, absorbed doses, and effective doses for the following radiopharmaceuticals: C-11-acetate; C-11-amino acids; C-11-brain receptor substances; C-11-methionine; F-18-amino acids; F-18-FET; F-18-FDG; In-111-monoclonal antibodies/fragments; I-123-fatty acids (BMIPP, IPPA); I-123-monoclonal antibodies/fragments; I-131-monoclonal antibodies/fragments; and Tl-201-ion. The publication also provides realistic maximum models for C-11 and F-18 substances, for which no specific models are available.

Recommended reference format for citations

ICRP, 2008. Radiation Dose to Patients from Radiopharmaceuticals - Addendum 3 to ICRP Publication 53. ICRP Publication 106. Ann. ICRP 38 (1-2).


Other Resources

4th addendum